Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan · Delayed Price · Currency is JPY 1,609.50
+11.50 (0.72%)
Sep 18, 2026, 3:30 PM JST
Sumitomo Pharma Market Cap
Sumitomo Pharma has a market cap or net worth of 722.01 billion as of September 18, 2026. Its market cap has increased by 12.32% in one year.
Market Cap
722.01B
Enterprise Value
806.03B
Revenue
474.79B
Ranking
n/a
PE Ratio
5.81
Stock Price
1,609.50
ChartMarket Cap Chart
Since January 14, 1992, Sumitomo Pharma's market cap has increased from 205.93B to 722.01B, an increase of 250.61%. That is a compound annual growth rate of 3.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 722.01B | -21.60% |
| Dec 30, 2025 | 920.92B | 311.72% |
| Dec 30, 2024 | 223.67B | 20.82% |
| Dec 29, 2023 | 185.14B | -53.35% |
| Dec 30, 2022 | 396.90B | -24.60% |
| Dec 30, 2021 | 526.41B | -13.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shionogi & | 2.51T |
| Eisai | 1.39T |
| Tsumura & Co. | 286.85B |
| Nippon Shinyaku | 232.67B |
| Sawai Group Holdings | 189.28B |
| Towa Pharmaceutical | 182.64B |
| Kissei Pharmaceutical | 166.02B |
| Kaken Pharmaceutical | 150.72B |